health
India Approves First Dengue Vaccine QDENGA After DCGI Clearance
Archived — last updated
India has approved its first dengue vaccine, QDENGA, developed by Takeda Biopharmaceuticals India, for people aged 4 to 60 years.
Latest updates
India Approves First Dengue Vaccine QDENGA After DCGI Clearance
India has approved its first dengue vaccine, QDENGA, developed by Takeda Biopharmaceuticals India, for people aged 4 to 60 years. The vaccine is approved for use in India, marking a major step in the country's fight against dengue.
India’s first dengue vaccine approved but lacks rollout strategy
The Union Health Ministry approved Qdenga, manufactured by Takeda, in March 2026 but has yet to finalize a distribution plan. Public health specialists cite the need for cold-chain infrastructure and prioritization of high-incidence regions like Delhi and Kerala. The vaccine’s efficacy stands at 80% against symptomatic dengue after two doses.
India Approves Takeda's TAK-003 Dengue Vaccine
The Indian government has approved Takeda's TAK-003 dengue vaccine, which is expected to provide protection against the disease in the country. The vaccine has been shown to be safe and effective in clinical trials, and is expected to be a valuable tool in the fight against dengue fever.
India Approves Takeda's TAK-003 Dengue Vaccine
India has approved Takeda's TAK-003 dengue vaccine, making it the country's first authorized dengue vaccine. The vaccine has been approved for use in India amid an eleven-fold surge in dengue cases over the past decade. The approval is seen as a significant step in the fight against dengue fever in India.
QDENGA: India’s first approved dengue vaccine
QDENGA, India’s first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts. Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two doses three months apart.
India Approves First Dengue Vaccine QDENGA
The Indian government has approved the country's first dengue vaccine, QDENGA. The vaccine is expected to improve healthcare outcomes in the country. QDENGA is the first dengue vaccine to be approved in India.
India Approves First Dengue Vaccine
The vaccine has been approved for use in India after successful clinical trials, which showed it to be 80% effective in preventing dengue fever. The vaccine is expected to be available in the market soon.
India Approves First Dengue Vaccine QDENGA
The Indian government has approved the country's first dengue vaccine, QDENGA, which has been developed by a domestic company. The vaccine is expected to provide protection against the mosquito-borne disease.
India’s First Approved Dengue Vaccine Gets Clearance
India's first approved dengue vaccine, QDENGA, has received clearance from the authorities. The vaccine is a significant development in the fight against dengue fever in India. According to The Hindu, the vaccine was approved on July 21, 2026.
CDSCO Grants Marketing Authorisation for India's First Dengue Vaccine
The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for India's first Dengue vaccine. The vaccine is expected to provide relief to patients suffering from Dengue fever.
India Gets First Dengue Vaccine
The vaccine, developed by a domestic firm, has been found to be safe and effective in clinical trials. The CDSCO has granted marketing authorisation, paving the way for its use in the country. The vaccine is expected to be launched soon.
India Gets Its First Dengue Vaccine
The vaccine has been developed by a domestic company and has undergone rigorous testing. It is expected to be available in the market soon.
India Approves First Dengue Vaccine for Individuals Aged 4-60
The Indian government has approved the dengue vaccine Qdenga for individuals aged 4-60. The vaccine has been cleared for use in the country after meeting the necessary safety and efficacy standards.
India Gets Its First Approved Dengue Vaccine; Qdenga Cleared for Individuals Aged 4–60
The approval of Qdenga marks a significant milestone in India's fight against dengue fever, which affects millions of people each year. The vaccine is expected to be widely available in the coming months.
Sources
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.